These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3346210)

  • 1. Alteration of epidermal growth factor receptor activity by mutation of its primary carboxyl-terminal site of tyrosine self-phosphorylation.
    Bertics PJ; Chen WS; Hubler L; Lazar CS; Rosenfeld MG; Gill GN
    J Biol Chem; 1988 Mar; 263(8):3610-7. PubMed ID: 3346210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the epidermal growth factor receptor by phosphorylation.
    Bertics PJ; Weber W; Cochet C; Gill GN
    J Cell Biochem; 1985; 29(3):195-208. PubMed ID: 3001110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3.
    Walker F; Hibbs ML; Zhang HH; Gonez LJ; Burgess AW
    Growth Factors; 1998; 16(1):53-67. PubMed ID: 9777370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multisite phosphorylation of the epidermal growth factor receptor. Use of site-directed mutagenesis to examine the role of serine/threonine phosphorylation.
    Countaway JL; McQuilkin P; Gironès N; Davis RJ
    J Biol Chem; 1990 Feb; 265(6):3407-16. PubMed ID: 2105948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of substitution of threonine 654 of the epidermal growth factor receptor on epidermal growth factor-mediated activation of phospholipase C.
    Decker SJ; Ellis C; Pawson T; Velu T
    J Biol Chem; 1990 Apr; 265(12):7009-15. PubMed ID: 2108964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational removal of the Thr669 and Ser671 phosphorylation sites alters substrate specificity and ligand-induced internalization of the epidermal growth factor receptor.
    Heisermann GJ; Wiley HS; Walsh BJ; Ingraham HA; Fiol CJ; Gill GN
    J Biol Chem; 1990 Aug; 265(22):12820-7. PubMed ID: 2115882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A site of tyrosine phosphorylation in the C terminus of the epidermal growth factor receptor is required to activate phospholipase C.
    Vega QC; Cochet C; Filhol O; Chang CP; Rhee SG; Gill GN
    Mol Cell Biol; 1992 Jan; 12(1):128-35. PubMed ID: 1729595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphorylation of phospholipase C-II in vitro by the epidermal growth factor receptor.
    Nishibe S; Wahl MI; Rhee SG; Carpenter G
    J Biol Chem; 1989 Jun; 264(18):10335-8. PubMed ID: 2732223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis.
    Honegger AM; Szapary D; Schmidt A; Lyall R; Van Obberghen E; Dull TJ; Ullrich A; Schlessinger J
    Mol Cell Biol; 1987 Dec; 7(12):4568-71. PubMed ID: 3501826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiloride directly inhibits growth factor receptor tyrosine kinase activity.
    Davis RJ; Czech MP
    J Biol Chem; 1985 Feb; 260(4):2543-51. PubMed ID: 2982824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements of the epidermal growth factor receptor for tyrosine phosphorylation of eps8 and eps15, substrates lacking Src SH2 homology domains.
    Alvarez CV; Shon KJ; Miloso M; Beguinot L
    J Biol Chem; 1995 Jul; 270(27):16271-6. PubMed ID: 7608194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation of ras GTPase-activating protein does not require association with the epidermal growth factor receptor.
    Soler C; Beguinot L; Sorkin A; Carpenter G
    J Biol Chem; 1993 Oct; 268(29):22010-9. PubMed ID: 8408058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
    Fan YX; Wong L; Deb TB; Johnson GR
    J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status.
    Kim YN; Wiepz GJ; Guadarrama AG; Bertics PJ
    J Biol Chem; 2000 Mar; 275(11):7481-91. PubMed ID: 10713051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
    Gill K; Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor stimulates phosphorylation of RAF-1 independently of receptor autophosphorylation and internalization.
    Baccarini M; Gill GN; Stanley ER
    J Biol Chem; 1991 Jun; 266(17):10941-5. PubMed ID: 1645717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent mechanisms account for the regulation by protein kinase C of the epidermal growth factor receptor affinity and tyrosine-protein kinase activity.
    Davis RJ
    J Biol Chem; 1988 Jul; 263(19):9462-9. PubMed ID: 3379075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of phosphorylation of the epidermal growth factor receptor at threonine 669.
    Countaway JL; Northwood IC; Davis RJ
    J Biol Chem; 1989 Jun; 264(18):10828-35. PubMed ID: 2543683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multiple endocrine neoplasia type 2B point mutation alters long-term regulation and enhances the transforming capacity of the epidermal growth factor receptor.
    Pandit SD; Donis-Keller H; Iwamoto T; Tomich JM; Pike LJ
    J Biol Chem; 1996 Mar; 271(10):5850-8. PubMed ID: 8621456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing.
    Honegger AM; Dull TJ; Felder S; Van Obberghen E; Bellot F; Szapary D; Schmidt A; Ullrich A; Schlessinger J
    Cell; 1987 Oct; 51(2):199-209. PubMed ID: 3499230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.